Abstract:Tong Guo, 1, 2 Yuan Feng, 1, 2 Jingjing Zhou, 1, 2 Linghui Meng, 1, 2 Xuequan Zhu, 1, 2 Xu Chen, 1, 2 Le Xiao, 1, 2 Lei Feng, 1, 2 Ling Zhang, 1, 2 Yu-Tao Xiang, 3, 4 Yan-Jie Zhao, 1, 2 Gang Wang 1, 2 1 Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, People's Republic of China; 2 Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, People's Republic of China; 3 Unit of Psychiatry, Department of Public Health and Medicinal Administration, Faculty of Health Sciences, Institute of Translational Medicine, University of Macau, Taipa, Macao SAR, People's Republic of China; 4 Centre for Cognitive and Brain Sciences, University of Macau, Taipa Macao SAR, People's Republic of China Correspondence: Yan-Jie Zhao; Gang Wang, Email ; Background: Understanding the dynamic relationship between depressive symptoms and quality of life (QOL) is essential in improving long-term outcomes for patients with Major Depressive Disorder (MDD). While previous studies often relied on cross-sectional data, there is a pressing need for stronger evidence based on longitudinal data to better inform the development of effective clinical interventions. By focusing on key depressive symptoms, such interventions have the potential to ultimately enhance QOL in individuals with MDD. Methods: This multi-center prospective study, conducted between 2016 and 2020, enrolled outpatients and inpatients diagnosed with MDD across twelve psychiatric hospitals in China. Longitudinal data on Patient Health Questionnaire – 9 (PHQ-9) and Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form (Q-LES-Q-SF) was analyzed using an Extended Bayesian Information Criterion (EBIC) graphical least absolute shrinkage and selection operator (gLASSO) network model to explore the connections between depressive symptom changes and QOL changes. Flow network was applied to investigate relationships between individual symptom changes and overall QOL score change, as well as daily functional independence. Results: This study included 818 participants with complete data after 8-week antidepressant treatment. Apart from the overlapping items from PHQ-9 and Q-LES-Q-SF, the three edges between "mood" (delta-QLES2) and "anhedonia" (delta-DEP1), between "physical health" (delta-QLES1) and "sleep problems" (delta-DEP3), and between "physical health" (delta-QLES1) and "sad mood" (delta-DEP2) were the most strong bridges between the cluster of depressive symptoms alleviation and the cluster of QOL change. "Anhedonia" (delta-DEP1), "sad mood" (delta-DEP2) and "loss of energy" (delta-DEP4) had the highest bridge strength between the alleviations of depressive symptoms and the total score change of Q-LES-Q-SF. Anhedonia had the greatest connection with participants' satisfaction with function in daily life. Conclusion: This study highlighted the potential for developing highly effective interventions by targeting on central symptoms, thereby to ultimately improve QOL for patients with MDD. Keywords: network analysis, patients with MDD, acute phase treatment, depressive symptoms, quality of life Major Depressive Disorder (MDD) is a common mental illness characterized by persistent low mood, loss of interest, and feelings of helplessness. According to previous systematic meta-analyses, the global prevalence of MDD is approximately 4.4%-5.0%, and has become one of the leading causes of disability worldwide. 1,2 In 2019, the Chinese Mental Health Survey (CMHS) showed that the lifetime prevalence of MDD was about 3.4%. 3,4 MDD poses a heavy burden on patients, families, and society and has become a major public health problem that needs to be addressed urgently. 5 In contemporary healthcare, there is a shifting emphasis towards the assessment of medium- and long-term disease outcomes, notably the Quality of Life (QOL), rather than focusing solely on symptom alleviation. 6 This shift aligns with a patient-centered approach, highlighting the importance of tailoring healthcare interventions to improve patients' overall QOL, addressing their unique needs and preferences. As healthcare continues to evolve, this emphasis on QOL will likely play a pivotal role in shaping treatment strategies and healthcare policies. While conventional pharmacotherapy and psychotherapy remain central to treating -Abstract Truncated-

The Effect of the Time to Remission on Residual Symptoms and Functioning among Depressive Patients.

Restoration of psychosocial functioning in remitted major depressive disorder patients: A 1-year longitudinal study

A National Survey of Residual Symptoms in Chinese Depressive Patients after Acute Phase Treatment

Psychosocial functioning and its influencing factors in patients with depression post-remission: Implications for assessment and interventions

The residual physical symptoms in Chinese patients with major depressive disorder after acute treatment phase: a cross-sectional survey among eleven mental health centers

Identifying the core residual symptom in patients with major depressive disorder using network analysis and illustrating its association with prognosis: A study based on the national cohorts in China

Factors influencing the tendency of residual symptoms in patients with depressive disorders: a longitudinal study

Association between residual symptoms and social functioning in patients with depression.

Unveiling the Interplay Between Depressive Symptoms' Alleviation and Quality of Life Improvement in Major Depressive Disorder: A Network Analysis Based on Longitudinal Data

Evaluations of Treatment Efficacy of Depression from Perspective of Both Patients' Symptoms and General Sense of Mental Health and Wellbeing: A Large Scale, Multi-Centered, Longitudinal Study in China.

Acute treatment residual depression symptoms and functional impairment among depressive patients of different age groups and education levels in China: A prospective, multicenter, randomized study

Association between the performance of executive function and the remission of depressive state after clinical treatment in patients with depression

A study on cognitive impairment during depression remission stage

Relationship between cognitive function and functional outcomes in remitted major depression

Associations Between Cognitive Symptoms and Functional Outcomes in Chinese Patients with Depression in a 6-Month Non-Interventional, Prospective Study

Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus

Does early and late life depression differ in residual symptoms, functioning and quality of life among the first-episode major depressive patients

Latent classes of symptom trajectories among major depressive disorder patients in China

Depressive symptoms in first-episode schizophrenia:A 9-year follow-up study

Predictors and moderators of quality of life in patients with major depressive disorder: An AGTs-MDD study report

SAT0117 THE IMPACT OF DIFFERENT CRITERIA SETS ON EARLY REMISSION AND IDENTIFYING ITS PREDICTORS IN RHEUMATOID ARTHRITIS: RESULTS FROM AN OBSERVATIONAL COHORT (2009–2018)